arrow
L

Li Yu

Xiamen University
H指数:25
被引数:2,431

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion

设计一种多价抗体纳米颗粒以克服SARS-CoV-2 Omicron免疫逃逸

2025-12-080
PRE
Manganese oxide nanozyme-loaded CO-releasing halloysite nanotubes for remodeling colonic immune, microbiota, and intestinal barrier homeostasis with concurrent pain relief in ulcerative colitis

载锰氧化物纳米酶的CO释放高岭土纳米管,用于重塑溃疡性结肠炎中结肠免疫、微生物群和肠道屏障稳态,并伴有疼痛缓解。

2025-10-012
OAAI
Polymerase Chain Reaction-Based Diagnosis of Leishmaniasis Targeting Kinetoplast Minicircle DNA in Infants with Hemophagocytic Lymphohistiocytosis

基于聚合酶链反应靶向婴儿噬血淋巴组织细胞增多症中动质最小环DNA的利什曼病诊断

2025-10-010
PRE
Clinical characteristics and severity of hand, foot, and mouth disease by virus serotype: A prospective hospital-based cohort study

手足口病临床特征与严重程度按病毒血清型分类:一项前瞻性医院为基础的队列研究

2025-05-230
OA
Tumor-resident microbiota contributes to colorectal cancer liver metastasis by lactylation and immune modulation

肿瘤驻留微生物通过乳酸和免疫调节促进结直肠癌肝转移

2024-06-185
OAAI
Two antibodies show broad, synergistic neutralization against SARS-CoV-2 variants by inducing conformational change within the RBD

两种抗体通过诱导RBD内的构象变化对SARS-CoV-2变体显示出广泛的协同中和作用

2023-07-203
OAAI
Immunological evaluation of an mRNA vaccine booster in individuals fully immunized with an inactivated SARS-CoV-2 vaccine
2022-06-095
OAAI
Preclinical immunological evaluation of an intradermal heterologous vaccine against SARS-CoV-2 variants
2022-01-075
OAAI
A human antibody of potent efficacy against SARS-CoV-2 in rhesus macaques showed strong blocking activity to B.1.351
MABS
IF7.3
2021-06-0713
OAAI
Clinical and Epidemiological Findings from Enhanced Monkeypox Surveillance in Tshuapa Province, Democratic Republic of the Congo During 2011-2015
2021-03-1684
OA
The prevalence of antibodies to SARS-CoV-2 among blood donors in China

中国献血者SARS-CoV-2抗体的患病率

2021-03-0238
OAAI